Chlorantholide B is primarily studied for its potential anti-inflammatory and neuroprotective properties. It has shown activity in modulating cellular pathways involved in inflammation, making it a candidate for research in neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. The compound may inhibit the release of pro-inflammatory cytokines and reduce oxidative stress in neuronal cells, which helps in preserving cell viability under pathological conditions. Due to its natural origin and structural complexity, it also serves as a lead compound in the development of novel therapeutics targeting central nervous system disorders. Current applications remain within preclinical research, focusing on understanding its mechanism of action and optimizing bioavailability for potential drug development.